Cargando…

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Considering the increasing number of identified driver oncogene alterations, additional genetic tests are required to determine the treatment for advanced non‐small‐cell lung cancer (NSCLC). Next‐generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakata, Shinya, Otsubo, Kohei, Yoshida, Hisako, Ito, Kentaro, Nakamura, Atsushi, Teraoka, Shunsuke, Matsumoto, Naohisa, Shiraishi, Yoshimasa, Haratani, Koji, Tamiya, Motohiro, Ikeda, Satoshi, Miura, Satoru, Tanizaki, Junko, Omori, Shota, Yoshioka, Hiroshige, Hata, Akito, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748216/ https://www.ncbi.nlm.nih.gov/pubmed/34704312 http://dx.doi.org/10.1111/cas.15176

Ejemplares similares

Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer
por: Iwama, Eiji, et al.
Publicado: (2023)

Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus
por: Vestergaard, Lau K., et al.
Publicado: (2021)

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)
por: Hayashi, Hidetoshi, et al.
Publicado: (2022)

Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples
por: Nemoto, Daiji, et al.
Publicado: (2020)

Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2022)

Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation
por: Sakaguchi, Tadashi, et al.
Publicado: (2023)

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)
por: Akamatsu, Hiroaki, et al.
Publicado: (2022)

FoundationOne CDx detected an uncovered variant of epidermal growth factor receptor exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma
por: Takahashi, Hiroki, et al.
Publicado: (2023)

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay
por: Olbryt, Magdalena, et al.
Publicado: (2021)

Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2020)

423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2020)

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L)
por: Miyawaki, Taichi, et al.
Publicado: (2021)

Validation of the Oncomine(™) focus panel for next-generation sequencing of clinical tumour samples
por: Williams, Hannah L., et al.
Publicado: (2018)

Expression patterns and clinical significances of PBK in lung cancer: an analysis based on Oncomine database
por: Li, Jinglei, et al.
Publicado: (2021)

Performance of Oncomine Fusion Transcript kit for formalin‐fixed, paraffin‐embedded lung cancer specimens
por: Sakai, Kazuko, et al.
Publicado: (2019)

Expression patterns and clinical significances of ENO2 in lung cancer: an analysis based on Oncomine database
por: Liu, Desen, et al.
Publicado: (2020)

Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer
por: Park, Joonhong, et al.
Publicado: (2020)

Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations
por: Cho, Yong Gon, et al.
Publicado: (2023)

Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)
por: Kato, Ryoji, et al.
Publicado: (2020)

The tunnel TT6 and TT70 towards TT60
por: CERN PhotoLab
Publicado: (1979)

DX centers
por: Munoz Merino, Elias
Publicado: (1994)

Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)
por: Tachihara, Motoko, et al.
Publicado: (2021)

Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
por: Sakai, Kazuko, et al.
Publicado: (2020)

Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis
por: Wilson, Brian J, et al.
Publicado: (2007)

A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays
por: Chaudhary, Sanjib, et al.
Publicado: (2017)

Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases
por: Cai, Pan, et al.
Publicado: (2021)

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G
por: Shitara, Kohei, et al.
Publicado: (2016)

Recent measurement of tt+V and tt+HF
por: Kuhl, Thorsten
Publicado: (2019)

Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing
por: Shin, Saeam, et al.
Publicado: (2017)

Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter
por: Hou, Guo-Xin, et al.
Publicado: (2017)

Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study
por: Bamba-Funck, Jessica, et al.
Publicado: (2023)

New results on TT2 TT10 matching
por: Chao Yu Chiu
Publicado: (2001)

TT2
Publicado: (1994)

TT2
Publicado: (1993)

TT2
Publicado: (2000)

Measuring the Ratio of σ(ttH)/σ(ttZ) in the ttH multilepton channel with the ATLAS detector
por: Halser, Lea
Publicado: (2018)

Measuring the Ratio of σ(ttH)/σ(ttZ) in the ttH multilepton channel with the ATLAS detector
por: Halser, Lea
Publicado: (2018)

基于Oncomine数据库荟萃分析KIF23在非小细胞肺癌中的表达和意义
Publicado: (2017)

Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases
por: Liu, Wei, et al.
Publicado: (2018)

Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database
por: Quan, Li-Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jq8o632cnmdqmroktk3ooh2di